Search results for "Dication"

showing 10 items of 733 documents

La dispense de revendication bénéficie à tous les propriétaires de biens mobiliers qui se trouvent confiés au débiteur en procédure collective par su…

2005

International audience; (Com. 15 mars 2005, Masson c/ Kessler, pourvoi n° 00-18.550, arrêt n° 444 FS-P+B+I+R, D. 2005.890, obs. A. Lienhard)

Dispense[SHS.DROIT]Humanities and Social Sciences/LawRevendication[SHS.DROIT] Humanities and Social Sciences/LawFonds de commerceREDRESSEMENT ET LIQUIDATION JUDICIAIRESActif
researchProduct

Crédit-bailleur. Rejet de la demande en restitution du crédit-bailleur dont le contrat n'a pas été publié correctement à la date du jugement d'ouvert…

2011

International audience; (Com. 11 mai 2010, n° 09-14.048, arrêt n° 524 F-P+B, Sté Credipar c/ K'Nevez et a., D. 2010. 1276, et les obs. ; Rev. sociétés 2010. 409, obs. P. Roussel Galle ; JCP 2010. 958, n° 12, obs. M. Cabrillac, et Act. 791, obs. J. Lasserre Capdeville)

Dispense[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawRevendicationSAUVEGARDE DES ENTREPRISESSauvegardeCrédit-bail
researchProduct

La prescripción farmacéutica en atención primaria. Informe SESPAS 2012

2012

ResumenEn 2010, el Sistema Nacional de Salud (SNS) facturó 958 millones de recetas. Dada la masiva exposición de la población a los medicamentos, los riesgos asociados a su consumo adquieren una enorme relevancia desde la perspectiva de salud pública. Pacientes sobremedicados en situaciones de bajo riesgo e inframedicados en situaciones de indicación demostrada, deficientemente informados, polimedicados, automedicados y un porcentaje no despreciable que sufre efectos adversos evitables, es en buena parte la fotografía de la prescripción en atención primaria que puede mejorarse. Sorprendentemente, la mayor parte de las estrategias farmacéuticas en el SNS no se han orientado al control de est…

Drug UtilizationPolypharmacymedicine.medical_specialtybusiness.industryMedical recordPublic healthPublic Health Environmental and Occupational HealthPrescription managementmedicine.diseaseAtención primariaPrimary carePrescriptionPharmaceutical expenditureGestión de la prescripciónGasto farmacéuticoPrescripciónHealth caremedicineAppropriatenessMedical emergencyMedical prescriptionbusinessPharmaceutical industrySelf-medicationAdecuaciónGaceta Sanitaria
researchProduct

Analysis of a possible association between oral lichen planus and drug intake. A controlled study

2010

Objectives: To investigate whether daily systemic and/or topical medication contributes to the development of oral lichen planus (OLP) lesions. Study Design: The study involved 110 OLP patients and 76 control subjects, matched by age, race and sex. The analyzed data included medical records, drug intake and topical medication. Criteria for analysis of drug intake included: (1) ATC-code drug classification; (2) number of different drugs used daily in the categories of monopharmacy (1 drug), minor polypharmacy (2 4 drugs), and major polypharmacy (> 5 drugs); and (3) drugs implicated in lichenoid reactions (DILRs). Results: Sixty (54.5%) of the 110 OLP patients reported daily medication (prior…

DrugAdultMalemedicine.medical_specialtymedia_common.quotation_subjectLesionstomatognathic systemOral administrationInternal medicinemedicineHumansGeneral Dentistrymedia_commonAgedPolypharmacyAged 80 and overbusiness.industryIncidence (epidemiology)Medical recordMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryTopical medicationstomatognathic diseasesOtorhinolaryngologyCase-Control StudiesUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusFemalemedicine.symptombusinessLichen Planus Oral
researchProduct

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

2017

International audience; PurposeTo provide an up-to-date account of drug prescription during pregnancy in France from 2011 to 2014 using the permanent sample of the French national computerized healthcare database and with a focus on recommended supplementations, fetotoxic drugs and teratogenic drugs.MethodsAll pregnancies identified by the International Classification of Diseases, 10th Revision codes list in the hospitalization database, lasting more than 9 weeks of amenorrhea and whose delivery occurred between 01/01/2011 and 12/31/2014, were included. Drugs delivered between the trimester before and until the end of the pregnancy were included. Drug exposure prevalence was calculated for …

DrugAdultPediatricsmedicine.medical_specialtypharmacoepidemiologyPrescription drugPrescription DrugsNational Health ProgramsEpidemiologymedia_common.quotation_subject[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicinePregnancymedicineHumansPharmacology (medical)Medical prescriptionPregnancy Trimestersmedia_commonPregnancy030219 obstetrics & reproductive medicinebusiness.industrydrug recommendationsadministrative healthcare databasePharmacoepidemiologymedicine.diseaseDrug classTeratogensprescription medicationsAmenorrheaFemaleFrancePregnancy Trimestersmedicine.symptombusinessPharmacoepidemiology and drug safety
researchProduct

Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry.

2021

PURPOSE The aim of this study was to analyze the epidemiology of polypharmacy in hospital psychiatry. Another aim was to investigate predictors of the number of drugs taken and the associated risks of drug-drug interactions and potentially inappropriate medications in the elderly. METHODS Daily prescription data were obtained from a pharmacovigilance project sponsored by the Innovations Funds of the German Federal Joint Committee. RESULTS The study included 47 071 inpatient hospital cases from eight different study centers. The mean number of different drugs during the entire stay was 6.1 (psychotropic drugs = 2.7; others = 3.4). The mean number of drugs per day was 3.8 (psychotropic drugs …

DrugMalemedicine.medical_specialtyEpidemiologymedia_common.quotation_subjectInappropriate Prescribing030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicinePharmacokineticsPharmacovigilanceEpidemiologyMedicineHumansPharmacology (medical)Drug Interactions030212 general & internal medicineRisk factorPsychiatryPotentially Inappropriate Medication Listmedia_commonAgedPolypharmacyPsychiatrybusiness.industryPharmacoepidemiologyHospitalsPsychotropic drugPharmaceutical PreparationsPolypharmacyFemalebusinessPharmacoepidemiology and drug safetyREFERENCES
researchProduct

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain.

2019

Abstract Background Drug treatment for secondary prevention of cardiovascular disease is recommended by guidelines, but it is not always followed in real life. This study wanted to assess the size of this gap and its impact on mortality in subjects after a cardiovascular event (MACE). Methods Patients with any of MACE in the period from January 1st 2011 to December 31st 2013, and more than one year of follow-up were selected from population of the Valencian Community. Drugs for secondary prevention were antiplatelets, renin-angiotensin system blockers and statins. Assessment of treatment was performed one year after the initial event. Mortality risk was assessed using Cox by the number of d…

DrugMalemedicine.medical_specialtyMedication Therapy Managementmedia_common.quotation_subjectmedicine.medical_treatmentPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsDisease030204 cardiovascular system & hematologyRevascularizationRisk Assessment03 medical and health sciencesAngiotensin Receptor Antagonists0302 clinical medicineInternal medicinemedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctioneducationStrokemedia_commonAgededucation.field_of_studybusiness.industryConfoundingmedicine.diseaseSurvival AnalysisProfessional Practice GapsStrokeSpainFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessMacePlatelet Aggregation InhibitorsInternational journal of cardiology
researchProduct

Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium

2022

OBJECTIVES: This study evaluates the impact of systemic medications and polypharmacy on unstimulated (UWS) and chewing-stimulated whole saliva (SWS) flow rates in patients with xerostomia.MATERIAL AND METHODS: This cross-sectional multicenter study is based on data of patients referred to five oral medicine outpatient practices in Europe and USA from January 2000 and April 2014. Relevant demographic, social, medical history and current medications were collected.RESULTS: The study included 1144 patients, 972 (85%) females, with a mean (SD) age of 59 (14.1) years. In unmatched patients, the UWS flow rate was lower in patients taking a medication (vs. not taking a medication) from the followi…

Drug-induced side effectSDG 3 - Good Health and Well-beingHyposalivation/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingDrug-induced side effectsMedicationSalivaGeneral DentistryXerostomia
researchProduct

The Diagnosis and Treatment of Peripheral Arterial Vascular Disease

2016

Background In peripheral arterial occlusive disease (PAOD), arterial stenosis or occlusion impairs perfusion in the territory of the distal portion of the aorta and the iliac and leg arteries. In Germany, the prevalence of PAOD rises with age, reaching 20% among persons over age 70. Methods This guideline was prepared by a collaboration of 22 medical specialty societies and two patient self-help organizations on the basis of pertinent publications that were retrieved by a systematic search in PubMed for articles that appeared from 2008 to April 2014, with a subsequent update to May 2015. Results 294 articles were assessed, including 34 systematic reviews and 98 randomized controlled trials …

Duplex ultrasonographymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPhysical examinationClinical Practice GuidelineGeneral MedicineGuideline030204 cardiovascular system & hematologyRevascularizationlaw.inventionSurgery03 medical and health sciences0302 clinical medicineBlood pressureRandomized controlled triallawArterial Occlusive DiseasesMedicine030212 general & internal medicinemedicine.symptombusinessClaudicationDeutsches Ärzteblatt international
researchProduct

Procédure et délai de revendication

2022

(Com. 29 juin 2022, no 21-13.706, F-D, Sté Frédéric Blanc MJO, ès qual., et a. c/ Sté Dotcorp Fine Art)

DélaiSauvegarde Des EntreprisesRevendication[SHS.DROIT] Humanities and Social Sciences/LawMeubleProcédure
researchProduct